Home The Word Brain My Amedeo FAQ Privacy About Flying Publisher   


The Angels Initiative

Stroke prevention


  Pulmonary Hypertension, May 2022

Free Subscription


Abstracts

Retrieve all available abstracts of the following 235 articles:
HTML format


 

Single Articles

  1. LI Y, Tung M, Xu J, Pan G, et al
    Perioperative Use of Pituitrin after Cardiac Defect Repair in Adult Patients with Severe Pulmonary Hypertension.
    Heart Surg Forum. 2022;25:E277-E283.
    PubMed    
    Abstract available

  2. VALERIO L, Mavromanoli AC, Barco S, Abele C, et al
    Chronic thromboembolic pulmonary hypertension and impairment after pulmonary embolism: the FOCUS study.
    Eur Heart J. 2022 Apr 28. pii: 6575686. doi: 10.1093.
    PubMed    
    Abstract available

  3. LI T, Liu B, Luo XJ, Peng J, et al
    VPO1/HOCl/ERK pathway mediates the right ventricular remodeling in rats with hypoxic pulmonary hypertension.
    Arch Biochem Biophys. 2022 Apr 25:109267. doi: 10.1016/j.abb.2022.109267.
    PubMed    
    Abstract available

  4. LAMBERT L, Michalek P, Burgetova A
    The diagnostic performance of CT pulmonary angiography in the detection of chronic thromboembolic pulmonary hypertension-systematic review and meta-analysis.
    Eur Radiol. 2022 Apr 28. pii: 10.1007/s00330-022-08804.
    PubMed    
    Abstract available

  5. WANG RR, Yuan TY, Chen D, Chen YC, et al
    Dan-Shen-Yin Granules Prevent Hypoxia-Induced Pulmonary Hypertension via STAT3/HIF-1alpha/VEGF and FAK/AKT Signaling Pathways.
    Front Pharmacol. 2022;13:844400.
    PubMed    
    Abstract available

  6. SUTO H, Suto M, Inui Y, Okamura A, et al
    Difficulty in Distinguishing Pulmonary Arterial Intimal Sarcoma from Pulmonary Thromboembolism Using FDG PET/CT.
    In Vivo. 2022;36:1519-1522.
    PubMed    
    Abstract available

  7. STUBBS H, MacLellan A, McGettrick M, Jani B, et al
    Predicting Group II pulmonary hypertension: diagnostic accuracy of the H2FPEF and OPTICS scores in Scotland.
    Open Heart. 2022;9.
    PubMed    
    Abstract available

  8. SATOH K
    Caspase-8 Promotes the Development of Pulmonary Hypertension.
    Arterioscler Thromb Vasc Biol. 2022 Apr 28:101161ATVBAHA122317727.
    PubMed    


  9. LIU B, Wei YP, Fan X, Hu X, et al
    Calcium Sensing Receptor Variants Increase Pulmonary Hypertension Susceptibility.
    Hypertension. 2022 Apr 28:101161HYPERTENSIONAHA12118399.
    PubMed    
    Abstract available

  10. YAMADA K, Matsukuma S, Tokumitsu Y, Shindo Y, et al
    Surgical shunt ligation for a congenital extrahepatic portosystemic shunt with pulmonary hypertension: A case report.
    Int J Surg Case Rep. 2022;93:107024.
    PubMed    
    Abstract available

  11. PFEUFFER-JOVIC E, Joa F, Halank M, Krannich JH, et al
    Anxiety, Depression and Quality of Life in Pulmonary Hypertension: A Comparison of Incident and Prevalent Cases.
    Respiration. 2022 Apr 27:1-9. doi: 10.1159/000524369.
    PubMed    
    Abstract available

  12. CHANG KY, Duval S, Badesch DB, Bull TM, et al
    Mortality in Pulmonary Arterial Hypertension in the Modern Era: Early Insights From the Pulmonary Hypertension Association Registry.
    J Am Heart Assoc. 2022 Apr 27:e024969. doi: 10.1161/JAHA.121.024969.
    PubMed    
    Abstract available

  13. HASHIMOTO H, Oka T, Nakanishi R, Mizumura S, et al
    Evaluation of balloon pulmonary angioplasty using lung perfusion SPECT in patients with chronic thromboembolic pulmonary hypertension.
    J Nucl Cardiol. 2022 Apr 26. pii: 10.1007/s12350-022-02971.
    PubMed    
    Abstract available

  14. RYAN A, Miah N, Saleh M
    Portopulmonary hypertension: a patient with shortness of breath.
    BMJ Case Rep. 2022;15.
    PubMed    
    Abstract available

  15. RAWAT M, Lakshminrusimha S, Vento M
    Pulmonary hypertension and oxidative stress: Where is the link?
    Semin Fetal Neonatal Med. 2022 Apr 19:101347. doi: 10.1016/j.siny.2022.101347.
    PubMed    
    Abstract available

  16. SUN Y, Wan W, Zhao X, Han X, et al
    Chronic Sigma 1 receptor activation alleviates right ventricular dysfunction secondary to pulmonary arterial hypertension.
    Bioengineered. 2022;13:10843-10856.
    PubMed    
    Abstract available

  17. ZHANG J, Du L, Qin X, Guo X, et al
    Effect of Sacubitril/Valsartan on the Right Ventricular Function and Pulmonary Hypertension in Patients With Heart Failure With Reduced Ejection Fraction: A Systematic Review and Meta-Analysis of Observational Studies.
    J Am Heart Assoc. 2022 Apr 26:e024449. doi: 10.1161/JAHA.121.024449.
    PubMed    
    Abstract available

  18. MILLER TF, Kaiser A, Schmelter T, Lippert J, et al
    Using real-world data in pediatric clinical trials: Lessons learned and future applications in studies of persistent pulmonary hypertension of the newborn.
    Semin Fetal Neonatal Med. 2022 Apr 8:101331. doi: 10.1016/j.siny.2022.101331.
    PubMed    
    Abstract available

  19. SURESH S, Charlton D, Snell EK, Laffoon M, et al
    Over one-third of Th/To antibody positive scleroderma patients develop pulmonary hypertension in long-term follow-up.
    Arthritis Rheumatol. 2022 Apr 25. doi: 10.1002/art.42152.
    PubMed    
    Abstract available

  20. JIAN Y, Zhou H, Wang Y, Zhang Z, et al
    Echocardiography-defined pulmonary hypertension is an adverse prognostic factor for newly diagnosed multiple myeloma patients.
    Cancer Med. 2022 Apr 24. doi: 10.1002/cam4.4770.
    PubMed    
    Abstract available

  21. NISHIYAMA A, Kawata N, Yokota H, Hayano K, et al
    Heterogeneity of Lung Density in Patients With Chronic Thromboembolic Pulmonary Hypertension (CTEPH).
    Acad Radiol. 2022 Apr 21. pii: S1076-6332(22)00141.
    PubMed    
    Abstract available

  22. MARRA AM, Benjamin N, Cittadini A, Bossone E, et al
    When Pulmonary Hypertension Complicates Heart Failure.
    Cardiol Clin. 2022;40:191-198.
    PubMed    
    Abstract available

  23. PICCARI L, Wort SJ, Meloni F, Rizzo M, et al
    The Effect of Borderline Pulmonary Hypertension on Survival in Chronic Lung Disease.
    Respiration. 2022 Apr 22:1-11. doi: 10.1159/000524263.
    PubMed    
    Abstract available

  24. ROZQIE R, Satwiko MG, Anggrahini DW, Sadewa AH, et al
    NKX2-5 variants screening in patients with atrial septal defect in Indonesia.
    BMC Med Genomics. 2022;15:91.
    PubMed    
    Abstract available

  25. ASSAGGAF H, Yoo C, Lucchini RG, Black SM, et al
    Polychlorinated Biphenyls and Pulmonary Hypertension.
    Int J Environ Res Public Health. 2022;19.
    PubMed    
    Abstract available

  26. WU Z, Zhou G, Wang H, Yao P, et al
    Inhibition of KIF23 Alleviates IPAH by Targeting Pyroptosis and Proliferation of PASMCs.
    Int J Mol Sci. 2022;23.
    PubMed    
    Abstract available

  27. LOOKIN O, Mukhlynina E, Protsenko Y
    Contractile Behavior of Right Atrial Myocardium of Healthy Rats and Rats with the Experimental Model of Pulmonary Hypertension.
    Int J Mol Sci. 2022;23.
    PubMed    
    Abstract available

  28. KARYOFYLLIS P, Demerouti E, Giannakoulas G, Anthi A, et al
    Balloon Pulmonary Angioplasty in Patients with Chronic Thromboembolic Pulmonary Hypertension in Greece: Data from the Hellenic Pulmonary Hypertension Registry.
    J Clin Med. 2022;11.
    PubMed    
    Abstract available

  29. BOXHAMMER E, Berezin AE, Paar V, Bacher N, et al
    Severe Aortic Valve Stenosis and Pulmonary Hypertension: A Systematic Review of Non-Invasive Ways of Risk Stratification, Especially in Patients Undergoing Transcatheter Aortic Valve Replacement.
    J Pers Med. 2022;12.
    PubMed    
    Abstract available

  30. TSUTSUMI Y, Adachi S, Nakano Y, Iwano S, et al
    End-Systolic Eccentricity Index Obtained by Enhanced Computed Tomography Is a Predictor of Pulmonary Vascular Resistance in Patients with Chronic Thromboembolic Pulmonary Hypertension.
    Life (Basel). 2022;12.
    PubMed    
    Abstract available

  31. RUDIENE V, Kapleriene L, Jancauskaite D, Meskene E, et al
    Pregnancy in Congenital Heart Disease, Complicated by Pulmonary Arterial Hypertension-A Challenging Issue for the Pregnant Woman, the Foetus, and Healthcare Professionals.
    Medicina (Kaunas). 2022;58.
    PubMed    
    Abstract available

  32. XU J, Linneman J, Zhong Y, Yin H, et al
    MicroRNAs in Pulmonary Hypertension, from Pathogenesis to Diagnosis and Treatment.
    Biomolecules. 2022;12.
    PubMed    
    Abstract available

  33. SANTOS-GOMES J, Le Ribeuz H, Bras-Silva C, Antigny F, et al
    Role of Ion Channel Remodeling in Endothelial Dysfunction Induced by Pulmonary Arterial Hypertension.
    Biomolecules. 2022;12.
    PubMed    
    Abstract available

  34. REDDY C, Kaskar A, Karthick E, Siddaiah S, et al
    Surgical Management of Aortopulmonary Window and its Associated Cardiac Lesions.
    World J Pediatr Congenit Heart Surg. 2022;13:334-340.
    PubMed    
    Abstract available

  35. MIYAKI R, Yamamura A, Kawade A, Fujiwara M, et al
    SKF96365 activates calcium-sensing receptors in pulmonary arterial smooth muscle cells.
    Biochem Biophys Res Commun. 2022;607:44-48.
    PubMed    
    Abstract available

  36. OLIVEIRA SD
    Insights on the Gut-Mesentery-Lung Axis in Pulmonary Arterial Hypertension: A Poorly Investigated Crossroad.
    Arterioscler Thromb Vasc Biol. 2022;42:516-526.
    PubMed    
    Abstract available

  37. SI L, Wang H, Jiang Y, Yi Y, et al
    MIR17HG polymorphisms contribute to high-altitude pulmonary edema susceptibility in the Chinese population.
    Sci Rep. 2022;12:4346.
    PubMed    
    Abstract available

  38. WANG J, Liu W, Lu W, Luo X, et al
    Sodium tanshinone IIA sulfonate enhances the BMP9-BMPR2-Smad1/5/9 signaling pathway in rat pulmonary microvascular endothelial cells and human embryonic stem cell-derived endothelial cells.
    Biochem Pharmacol. 2022;199:114986.
    PubMed    
    Abstract available

  39. LI M, Tian Z, Qian J, Huang C, et al
    Impact of pregnancy in patients with systemic lupus erythematosus-associated pulmonary arterial hypertension: case series and literature review.
    Lupus Sci Med. 2022;9.
    PubMed    
    Abstract available

  40. KIMMIG LM, Stutz MR, Husain AN, Bag R, et al
    Identification of a Novel EIF2AK Variant and Genetics-Assisted Approach to Diagnosis of Pulmonary Capillary Hemangiomatosis.
    Lung. 2022;200:217-219.
    PubMed    
    Abstract available

  41. SHAO B, Hoover C, Shi H, Kondo Y, et al
    Deletion of platelet CLEC-2 decreases GPIbalpha-mediated integrin alphaIIbbeta3 activation and decreases thrombosis in TTP.
    Blood. 2022;139:2523-2533.
    PubMed    
    Abstract available

  42. LIU A, Li B, Yang M, Shi Y, et al
    Targeted treprostinil delivery inhibits pulmonary arterial remodeling.
    Eur J Pharmacol. 2022;923:174700.
    PubMed    
    Abstract available

  43. HU L, Zhao C, Chen Z, Hu G, et al
    An emerging strategy for targeted therapy of pulmonary arterial hypertension: Vasodilation plus vascular remodeling inhibition.
    Drug Discov Today. 2022;27:1457-1463.
    PubMed    
    Abstract available

  44. HUANG CX, Jiang ZX, Du DY, Zhang ZM, et al
    The MFF-SIRT1/3 axis, regulated by miR-340-5p, restores mitochondrial homeostasis of hypoxia-induced pulmonary artery smooth muscle cells.
    Lab Invest. 2022;102:515-523.
    PubMed    
    Abstract available

  45. FETANAT M, Stevens M, Jain P, Hayward C, et al
    Fully Elman Neural Network: A Novel Deep Recurrent Neural Network Optimized by an Improved Harris Hawks Algorithm for Classification of Pulmonary Arterial Wedge Pressure.
    IEEE Trans Biomed Eng. 2022;69:1733-1744.
    PubMed    
    Abstract available

  46. FERGUSON-SELLS L, Velez de Mendizabal N, Li B, Small D, et al
    Population Pharmacokinetics of Tadalafil in Pediatric Patients with Pulmonary Arterial Hypertension: A Combined Adult/Pediatric Model.
    Clin Pharmacokinet. 2022;61:249-262.
    PubMed    
    Abstract available

  47. ZHANG F, Chen A, Pan Y, Wang X, et al
    Research Progress on Pulmonary Arterial Hypertension and the Role of the Angiotensin Converting Enzyme 2-Angiotensin-(1-7)-Mas Axis in Pulmonary Arterial Hypertension.
    Cardiovasc Drugs Ther. 2022;36:363-370.
    PubMed    
    Abstract available

  48. SAADI S, Masmoudi T, Ben Daly A, Jedidi M, et al
    Pulmonary alveolar capillary dysplasia in infants: A rare and deadly missed diagnosis.
    Ann Cardiol Angeiol (Paris). 2022;71:112-114.
    PubMed    
    Abstract available

  49. GAVELA J, Sharma S, Thompson D, Cocca A, et al
    Presentation of cardiogenic shock with pulmonary hypertension and arrhythmia secondary to foramen magnum stenosis in a patient with achondroplasia.
    J Paediatr Child Health. 2022 May 5. doi: 10.1111/jpc.16005.
    PubMed    


  50. DAI LL, Jiang TC, Li PF, Shao H, et al
    Predictors of Maternal Death Among Women With Pulmonary Hypertension in China From 2012 to 2020: A Retrospective Single-Center Study.
    Front Cardiovasc Med. 2022;9:814557.
    PubMed    
    Abstract available

  51. GUO J, Liu B, Thorikay M, Yu M, et al
    Crystal structures of BMPRII extracellular domain in binary and ternary receptor complexes with BMP10.
    Nat Commun. 2022;13:2395.
    PubMed    
    Abstract available

  52. HU L, Wang J, Lin D, Shen Y, et al
    Mesenchymal Stem Cell-Derived Nanovesicles as a Credible Agent for Therapy of Pulmonary Hypertension.
    Am J Respir Cell Mol Biol. 2022 May 4. doi: 10.1165/rcmb.2021-0415.
    PubMed    
    Abstract available

  53. JANSA P, Ambroz D, Kuhn M, Dytrych V, et al
    Epidemiology of chronic thromboembolic pulmonary hypertension (CTEPH) in the Czech Republic.
    Pulm Circ. 2022;12:e12038.
    PubMed    
    Abstract available

  54. APPENZELLER P, Lichtblau M, Berlier C, Aubert JD, et al
    Disease characteristics and clinical outcome over two decades from the Swiss pulmonary hypertension registry.
    Pulm Circ. 2022;12:e12001.
    PubMed    
    Abstract available

  55. SAITO S, Ikeda N, Iijima R, Hara H, et al
    Evaluation of the effect of nitric oxide inhalation in the patients with chronic thromboembolic pulmonary hypertension or pulmonary disease during balloon pulmonary angioplasty.
    Pulm Circ. 2022;12:e12032.
    PubMed    
    Abstract available

  56. FROST AE, Moore LW, Valdivia E Alvarado M, Obi C, et al
    The echocardiographic course of pretransplant pulmonary hypertension following kidney transplantation and associated outcomes.
    Pulm Circ. 2022;12:e12030.
    PubMed    
    Abstract available

  57. STERNBERG ME, Grinnan D, Gertz ZM
    Utility of plasma volume status in ambulatory patients with pulmonary hypertension.
    Pulm Circ. 2022;12:e12045.
    PubMed    
    Abstract available

  58. COOK DP, Xu M, Martucci VL, Annis JS, et al
    Clinical insights into pulmonary hypertension in chronic obstructive pulmonary disease.
    Pulm Circ. 2022;12:e12006.
    PubMed    
    Abstract available

  59. BOULATE D, Loisel F, Coblence M, Provost B, et al
    Pulsatile pulmonary artery pressure in a large animal model of chronic thromboembolic pulmonary hypertension: Similarities and differences with human data.
    Pulm Circ. 2022;12:e12017.
    PubMed    
    Abstract available

  60. SULLIVAN RT, Lo C, Martin E, Kameny RJ, et al
    A case of acquired von Willebrand disease in severe pediatric pulmonary hypertension contributing to bleeding following reverse Potts shunt.
    Pulm Circ. 2022;12:e12042.
    PubMed    
    Abstract available

  61. LUO D, Xie N, Yang Z, Zhang C, et al
    Association of nutritional status and mortality risk in patients with primary pulmonary hypertension.
    Pulm Circ. 2022;12:e12018.
    PubMed    
    Abstract available

  62. WIJERATNE DT, Housin A, Lajkosz K, Lougheed MD, et al
    Using health administrative data to identify patients with pulmonary hypertension: A single center, proof of concept validation study in Ontario, Canada.
    Pulm Circ. 2022;12:e12040.
    PubMed    
    Abstract available

  63. MITROUSKA I, Bolaki M, Vaporidi K, Georgopoulos D, et al
    Respiratory system as the main determinant of dyspnea in patients with pulmonary hypertension.
    Pulm Circ. 2022;12:e12060.
    PubMed    
    Abstract available

  64. RABIH F, Holden RL, Vasanth P, Pastan SO, et al
    Effect of pulmonary hypertension on 5-year outcome of kidney transplantation.
    Pulm Circ. 2022;12:e12010.
    PubMed    
    Abstract available

  65. KOZITZA CJ, Dharmavaram N, Tao R, Tabima DM, et al
    Pulmonary vascular distensibility with passive leg raise is comparable to exercise and predictive of clinical outcomes in pulmonary hypertension.
    Pulm Circ. 2022;12:e12029.
    PubMed    
    Abstract available

  66. OROZCO-LEVI M, Caneva J, Fernandes C, Restrepo-Jaramillo R, et al
    Differences in health policies for drug availability in pulmonary arterial hypertension and chronic thromboembolic pulmonary hypertension across Latin America.
    Pulm Circ. 2022;12:e12012.
    PubMed    
    Abstract available

  67. STEVENS L, Colglazier E, Parker C, Amin EK, et al
    Genetics dictating therapeutic decisions in pediatric pulmonary hypertension? A case report suggesting we are getting closer.
    Pulm Circ. 2022;12:e12033.
    PubMed    
    Abstract available

  68. OLIVEIRA AC, Yang T, Li J, Sharma RK, et al
    Fecal matter transplant from Ace2 overexpressing mice counteracts chronic hypoxia-induced pulmonary hypertension.
    Pulm Circ. 2022;12:e12015.
    PubMed    
    Abstract available

  69. KING NE, Brittain E
    Emerging therapies: The potential roles SGLT2 inhibitors, GLP1 agonists, and ARNI therapy for ARNI pulmonary hypertension.
    Pulm Circ. 2022;12:e12028.
    PubMed    
    Abstract available

  70. SIMPSON CE, Kolb TM, Hsu S, Zimmerman SL, et al
    Ventricular mass discriminates pulmonary arterial hypertension as redefined at the Sixth World Symposium on Pulmonary Hypertension.
    Pulm Circ. 2022;12:e12005.
    PubMed    
    Abstract available

  71. WARDLE M, Nair A, Saunders S, Armstrong I, et al
    Elective lower limb orthopedic arthroplasty surgery in patients with pulmonary hypertension.
    Pulm Circ. 2022;12:e12019.
    PubMed    
    Abstract available

  72. MARON BA, Choudhary G, Goldstein RL, Garshick E, et al
    Tadalafil for veterans with chronic obstructive pulmonary disease-pulmonary hypertension: A multicenter, placebo-controlled randomized trial.
    Pulm Circ. 2022;12:e12043.
    PubMed    
    Abstract available

  73. HANDLER SS, Varghese NP, Rosenzweig EB, Yung D, et al
    Building a dedicated pediatric pulmonary hypertension program: A consensus statement from the pediatric pulmonary hypertension network.
    Pulm Circ. 2022;12:e12031.
    PubMed    
    Abstract available

  74. CHEN T, Sun MR, Zhou Q, Guzman AM, et al
    Extracellular vesicles derived from endothelial cells in hypoxia contribute to pulmonary artery smooth muscle cell proliferation in-vitro and pulmonary hypertension in mice.
    Pulm Circ. 2022;12:e12014.
    PubMed    
    Abstract available

  75. BESHAY S, Humbert M, Barrios R, Sahay S, et al
    Progression of pulmonary veno-occlusive disease without pulmonary hypertension.
    Pulm Circ. 2022;12:e12046.
    PubMed    
    Abstract available

  76. GOYA S, Yoshida T, Sennba S, Uchide T, et al
    Adjunct ambrisentan therapy had clinical benefits in 5 dogs with sildenafil-refractory pulmonary hypertension.
    Can Vet J. 2022;63:497-503.
    PubMed    
    Abstract available

  77. BURMEISTER C, Ghazaleh S, Beran A, Patel N, et al
    Head-to-head comparison between direct oral anticoagulants and vitamin K antagonists for chronic thromboembolic pulmonary hypertension: a systematic review and meta-analysis.
    Curr Probl Cardiol. 2022 Apr 29:101232. doi: 10.1016/j.cpcardiol.2022.101232.
    PubMed    


  78. GADIOLI LP, Costa FA, Moreira HT, Crescencio JC, et al
    Use of Cardiopulmonary Exercise Testing to Assess Pulmonary Hypertension in Patients with Rheumatic Mitral Valve Disease: A Comparative Study with Echocardiography.
    Curr Probl Cardiol. 2022 Apr 29:101230. doi: 10.1016/j.cpcardiol.2022.101230.
    PubMed    
    Abstract available

  79. HAJRA A, Safiriyu I, Balasubramanian P, Gupta R, et al
    Recent Advances and Future Prospects of Treatment of Pulmonary Hypertension.
    Curr Probl Cardiol. 2022 Apr 29:101236. doi: 10.1016/j.cpcardiol.2022.101236.
    PubMed    
    Abstract available

  80. SUZUKI R, Yuchi Y, Saito T, Teshima T, et al
    Investigation of Beraprost Sodium on Cardiac Function and Hemodynamics in Canine Models of Chronic Pulmonary Hypertension.
    Front Vet Sci. 2022;9:876178.
    PubMed    
    Abstract available

  81. BOYLE TA, Daimee UA, Simpson CE, Kolb TM, et al
    Left atrial ablation for the management of atrial tachyarrhythmias in patients with pulmonary hypertension: A case series.
    HeartRhythm Case Rep. 2022;8:275-279.
    PubMed    


  82. YANAKA K, Nakayama K, Taniguchi Y, Onishi H, et al
    RC time (resistance x compliance) is related to residual symptom after pulmonary endarterectomy in chronic thromboembolic pulmonary hypertension.
    Int J Cardiol Heart Vasc. 2022;40:101031.
    PubMed    
    Abstract available

  83. WATANABE M, Higuchi R, Nanasato M, Iguchi N, et al
    Thromboembolic Pulmonary Hypertension Induced Myocardial Ischemia in a Patient With Anomalous Right Coronary Artery.
    Circ J. 2022 Apr 29. doi: 10.1253/circj.CJ-22-0115.
    PubMed    


  84. ADEOTI AO, Nadar A, Channa ML
    Targeting Apoptosis Signal-Regulating Kinase-1 (ASK-1) As a Biomarker of Monocrotaline-Induced Pulmonary Hypertension following Administration of Antiretroviral Medications in Rat Model.
    West Afr J Med. 2022;39:394-398.
    PubMed    
    Abstract available

  85. HIGUCHI S, Ota H, Yaoita N, Kamada H, et al
    Update on the roles of imaging in the management of chronic thromboembolic pulmonary hypertension.
    J Cardiol. 2022 Apr 27. pii: S0914-5087(22)00053.
    PubMed    
    Abstract available

  86. JIANG XK, Xiao YY, Ye Q, Meng XF, et al
    [Risk factors for syncope in children with severe idiopathic pulmonary arterial hypertension].
    Zhonghua Er Ke Za Zhi. 2022;60:442-446.
    PubMed    
    Abstract available

  87. MIAO R, Gong J, Guo X, Guo D, et al
    Diagnostic value of miRNA expression and right ventricular echocardiographic functional parameters for chronic thromboembolic pulmonary hypertension with right ventricular dysfunction and injury.
    BMC Pulm Med. 2022;22:171.
    PubMed    
    Abstract available

  88. MADDEN BA, Conaway MR, Zanelli SA, McCulloch MA, et al
    Screening Echocardiography Identifies Risk Factors for Pulmonary Hypertension at Discharge in Premature Infants with Bronchopulmonary Dysplasia.
    Pediatr Cardiol. 2022 Apr 29. pii: 10.1007/s00246-022-02911.
    PubMed    
    Abstract available

  89. CHARTERS PFP, Rossdale J, Brown W, Burnett TA, et al
    Diagnostic accuracy of an automated artificial intelligence derived right ventricular to left ventricular diameter ratio tool on CT pulmonary angiography to predict pulmonary hypertension at right heart catheterisation.
    Clin Radiol. 2022 Apr 26. pii: S0009-9260(22)00163.
    PubMed    
    Abstract available

  90. MICKAEL C, Kheyfets VO, Langouet-Astrie C, Lee MH, et al
    Peripheral Blood Inflammation Profile of Patients with Pulmonary Arterial Hypertension Using the High-Throughput Olink Proteomics Platform.
    Am J Respir Cell Mol Biol. 2022;66:580-581.
    PubMed    


  91. ZHANG F, Zheng Z, Gong T, Zhu Z, et al
    Anesthesia Management of a Premature Neonate with Congenital Heart Disease during Emergency Diaphragmatic Hernia Surgery: A Case Report.
    Heart Surg Forum. 2022;25:E273-E276.
    PubMed    
    Abstract available

  92. TENNOE AH, Murbraech K, Didriksen H, Ueland T, et al
    Serum markers of cardiac complications in a systemic sclerosis cohort.
    Sci Rep. 2022;12:4661.
    PubMed    
    Abstract available

  93. VALASARAJAN C, Karger A, Savai R, Pullamsetti SS, et al
    Long Noncoding RNAs: Emerging Regulators of Platelet-derived Growth Factor Signaling.
    Am J Respir Cell Mol Biol. 2022;66:473-475.
    PubMed    


  94. DE GROOTE P, Delobelle M, Hebbar E, Mercier T, et al
    Right heart catheterization in advanced systolic heart failure. What are the most useful haemodynamic parameters for risk stratification?
    Arch Cardiovasc Dis. 2022;115:169-178.
    PubMed    
    Abstract available

  95. YATES AR, Berger JT, Reeder RW, Banks R, et al
    Characterization of Inhaled Nitric Oxide Use for Cardiac Indications in Pediatric Patients.
    Pediatr Crit Care Med. 2022;23:245-254.
    PubMed    
    Abstract available

  96. MARWICK TH
    Peripheral Venous Pressure: An Important but Neglected Contributor to Echocardiographic Estimation of Pulmonary Artery Pressure With Exercise.
    Circ Heart Fail. 2022 Feb 22:CIRCHEARTFAILURE121009383.
    PubMed    


  97. LE RIBEUZ H, Masson B, Capuano V, Dutheil M, et al
    SUR1 As a New Therapeutic Target for Pulmonary Arterial Hypertension.
    Am J Respir Cell Mol Biol. 2022;66:539-554.
    PubMed    
    Abstract available

  98. DJOKOVIC A, Stojanovich L, Stanisavljevic N, Djokic S, et al
    Cardiac manifestations in primary antiphospholipid syndrome and their association to antiphospholipid antibodies' types and titers-cross-sectional study of Serbian cohort.
    Clin Rheumatol. 2022;41:1447-1455.
    PubMed    
    Abstract available

  99. UMEMOTO S, Abe K, Hosokawa K, Horimoto K, et al
    Increased Pulmonary Arterial Compliance after Balloon Pulmonary Angioplasty Predicts Exercise Tolerance Improvement in Inoperable CTEPH Patients with Lower Pulmonary Arterial Pressure.
    Heart Lung. 2022;52:8-15.
    PubMed    
    Abstract available

  100. HAN Z, Li X, Cui X, Yuan H, et al
    The roles of immune system and autoimmunity in pulmonary arterial hypertension: A review.
    Pulm Pharmacol Ther. 2022;72:102094.
    PubMed    
    Abstract available

  101. WELLER K, Peters NCJ, van Rosmalen J, Cochius-Den Otter SCM, et al
    Prenatal stomach position and volume in relation to postnatal outcomes in left-sided congenital diaphragmatic hernia.
    Prenat Diagn. 2022;42:338-347.
    PubMed    
    Abstract available

  102. HOCQ C, Vanhoutte L, Guilloteau A, Massolo AC, et al
    Early diagnosis and targeted approaches to pulmonary vascular disease in bronchopulmonary dysplasia.
    Pediatr Res. 2022;91:804-815.
    PubMed    
    Abstract available

  103. BALIEVA I, Chauke L, Wise A, Voors AA, et al
    Pregnancy in women with cardiac disease: a one-year retrospective review of management and maternal and neonatal outcomes in a tertiary hospital in Johannesburg, South Africa.
    Cardiovasc J Afr. 2021;32:301-307.
    PubMed    
    Abstract available

  104. SANTOS JG, Ferreira F, Alegria S, Pereira H, et al
    Anomalous origin of the left pulmonary artery from the ascending thoracic aorta and a right patent ductus arteriosus associated with pulmonary hypertension in a woman of childbearing age: an unprecedented approach.
    BMJ Case Rep. 2022;15.
    PubMed    
    Abstract available

  105. SPILIMBERGO FB, Assmann TS, Bellon M, Hoscheidt LM, et al
    Soluble Guanylate Cyclase Stimulators (Riociguat) in Pulmonary Hypertension: Data from Real-Life Clinical Practice in a 3-Year Follow-Up.
    Arq Bras Cardiol. 2022 May 9. pii: S0066-782X2022005006202.
    PubMed    
    Abstract available

  106. SMITS AJ, Arkani M, In 't Veld SGJG, Huis In 't Veld AE, et al
    Distinct Platelet RNA Signatures in Patients with Pulmonary Hypertension.
    Ann Am Thorac Soc. 2022 May 10. doi: 10.1513/AnnalsATS.202201.
    PubMed    
    Abstract available

  107. TSUJIMOTO Y, Kumasawa J, Shimizu S, Nakano Y, et al
    Doppler trans-thoracic echocardiography for detection of pulmonary hypertension in adults.
    Cochrane Database Syst Rev. 2022;5:CD012809.
    PubMed    
    Abstract available

  108. PILIERO N, Thony F, Guillien A, Rousseau J, et al
    Balloon pulmonary angioplasty for chronic thromboembolic pulmonary hypertension: Evaluation of haemodynamic effects, complication rates and radiation exposure over time.
    Arch Cardiovasc Dis. 2022 Apr 21. pii: S1875-2136(22)00055.
    PubMed    
    Abstract available

  109. HONG C, Lu J, Wu X, Guo W, et al
    Bilateral versus unilateral balloon pulmonary angioplasty for inoperable chronic thromboembolic pulmonary hypertension.
    Respir Res. 2022;23:117.
    PubMed    
    Abstract available

  110. MANDURINO-MIRIZZI A, Munafo A, Raineri C, Magrini G, et al
    Response to acute vasodilator challenge and haemodynamic modifications after MitraClip in patients with functional mitral regurgitation and pulmonary hypertension.
    Eur Heart J Acute Cardiovasc Care. 2022 May 7. pii: 6582251.
    PubMed    
    Abstract available

  111. XIANG G, Ying K, Jiang P, Jia M, et al
    Growth differentiation factor 11 induces skeletal muscle atrophy via a STAT3-dependent mechanism in pulmonary arterial hypertension.
    Skelet Muscle. 2022;12:10.
    PubMed    
    Abstract available

  112. GONCHAROVA EA, Farkas L
    Stem Cell-Derived Nanovesicles for the Treatment of Pulmonary Hypertension: Are We There Yet?
    Am J Respir Cell Mol Biol. 2022 May 6. doi: 10.1165/rcmb.2022-0078.
    PubMed    


  113. LI Q, Zhang C, Wang R, Keller BB, et al
    Pulmonary hypertensive crisis in children with pulmonary arterial hypertension undergoing cardiac catheterization.
    Pulm Circ. 2022;12:e12067.
    PubMed    
    Abstract available

  114. SCHMIDT C, Monteiro M, Furtado I, Carvalho L, et al
    Physical activity and its clinical correlates in chronic thromboembolic pulmonary hypertension.
    Pulm Circ. 2022;12:e12048.
    PubMed    
    Abstract available

  115. NIES MK, Yang J, Griffiths M, Damico R, et al
    Proteomics discovery of pulmonary hypertension biomarkers: Insulin-like growth factor binding proteins are associated with disease severity.
    Pulm Circ. 2022;12:e12039.
    PubMed    
    Abstract available

  116. SINKALA E, Ahmed HY, Sibomana JP, Lee MH, et al
    Rationale and design of a screening study to detect schistosomiasis-associated pulmonary hypertension in Ethiopia and Zambia.
    Pulm Circ. 2022;12:e12072.
    PubMed    
    Abstract available

  117. RAWLINGS GH, Beail N, Condliffe R, Kiely DG, et al
    Examining the impact of pulmonary hypertension on nonprofessional caregivers: A mixed-methods systematic review.
    Pulm Circ. 2022;12:e12077.
    PubMed    
    Abstract available

  118. RAHAGHI FF, Balasubramanian VP, Bourge RC, Burger CD, et al
    Delphi consensus recommendation for optimization of pulmonary hypertension therapy focusing on switching from a phosphodiesterase 5 inhibitor to riociguat.
    Pulm Circ. 2022;12:e12055.
    PubMed    
    Abstract available

  119. BLANCO I, Torres-Castro R, Barbera JA
    [Translated article] Exercise Tolerance in Pulmonary Hypertension.
    Arch Bronconeumol. 2022 May 2. pii: S0300-2896(22)00306.
    PubMed    


  120. PADREZ Y, Golubewa L, Kulahava T, Vladimirskaja T, et al
    Quantitative and qualitative analysis of pulmonary arterial hypertension fibrosis using wide-field second harmonic generation microscopy.
    Sci Rep. 2022;12:7330.
    PubMed    
    Abstract available

  121. RHEE SJ, Shin SH, Oh J, Jung YH, et al
    Population pharmacokinetic analysis of sildenafil in term and preterm infants with pulmonary arterial hypertension.
    Sci Rep. 2022;12:7393.
    PubMed    
    Abstract available

  122. PEREIRA MC, Lima LNG, Moreira MM, Mendes FAR, et al
    One minute sit-to-stand test as an alternative to measure functional capacity in patients with pulmonary arterial hypertension.
    J Bras Pneumol. 2022;48:e20210483.
    PubMed    


  123. ZHANG Y, Hernandez M, Gower J, Winicki N, et al
    JAGGED-NOTCH3 signaling in vascular remodeling in pulmonary arterial hypertension.
    Sci Transl Med. 2022;14:eabl5471.
    PubMed    
    Abstract available

  124. ZHANG Y, Michelakis ED
    Changing cell fate in the wall of pulmonary arteries.
    Sci Transl Med. 2022;14:eabq1908.
    PubMed    
    Abstract available

  125. JARABICOVA I, Horvath C, Velasova E, Bies Pivackova L, et al
    Analysis of necroptosis and its association with pyroptosis in organ damage in experimental pulmonary arterial hypertension.
    J Cell Mol Med. 2022;26:2633-2645.
    PubMed    
    Abstract available

  126. THOMEAS-MCEWING V, Psotka MA, Gamazon ER, Friedman P, et al
    Two polymorphic gene loci associated with treprostinil dose in pulmonary arterial hypertension.
    Pharmacogenet Genomics. 2022;32:144-151.
    PubMed    
    Abstract available

  127. STUBBE B, Halank M, Seyfarth HJ, Obst A, et al
    [Risk Stratification in Patients with Pulmonary Arterial Hypertension under Treatment - Results of Four German Centers].
    Pneumologie. 2022;76:330-339.
    PubMed    
    Abstract available

  128. HUANG Z, Gao D, Liu Z, Liu X, et al
    Long-term outcomes and prognostic predictors of patients with Takayasu's arteritis along with pulmonary artery involvement.
    Clin Exp Rheumatol. 2022;40:765-771.
    PubMed    
    Abstract available

  129. CRUZ-UTRILLA A, Gallego N, Torrent-Vernetta A, Guillen I, et al
    Prevalence of genetic variants in pediatric pulmonary arterial hypertension associated with corrected D-transposition of the great arteries. The REHIPED registry.
    Rev Esp Cardiol (Engl Ed). 2022;75:448-450.
    PubMed    


  130. SAMEEMA VV, Soni K, Deora S, Sharma JB, et al
    Assessment of preoperative and postoperative cardiac function in children with adenotonsillar hypertrophy: a prospective cohort study.
    Eur Arch Otorhinolaryngol. 2022;279:3013-3019.
    PubMed    
    Abstract available

  131. BAYRAM Z, Dogan C, Efe SC, Guvendi B, et al
    Ischaemic versus non-ischaemic: how does heart failure aetiology affect pulmonary arterial capacitance and pulmonary artery pulsatility index in end-stage heart failure?
    Acta Cardiol. 2022;77:204-210.
    PubMed    
    Abstract available

  132. SPIERINGS J, Nihtyanova SI, Derrett-Smith E, Clark KEN, et al
    Outcomes linked to eligibility for stem cell transplantation trials in diffuse cutaneous systemic sclerosis.
    Rheumatology (Oxford). 2022;61:1948-1956.
    PubMed    
    Abstract available

  133. KAMELY M, Karimi Torshizi MA, West J, Niewold T, et al
    Impacts of caffeine on resistant chicken's performance and cardiovascular gene expression.
    J Anim Physiol Anim Nutr (Berl). 2022;106:566-574.
    PubMed    
    Abstract available

  134. SHI B, Zhou T, Lv S, Wang M, et al
    An evolutionary machine learning for pulmonary hypertension animal model from arterial blood gas analysis.
    Comput Biol Med. 2022;146:105529.
    PubMed    
    Abstract available

  135. OKAMURA M, Konishi M, Saigusa Y, Ando S, et al
    Impact of grip strength and gait speed on exercise tolerance in patients with pulmonary hypertension without left heart disease.
    Heart Vessels. 2022 May 20. pii: 10.1007/s00380-022-02091.
    PubMed    
    Abstract available

  136. CODINA P, Domingo M, Barcelo E, Gastelurrutia P, et al
    Sacubitril/valsartan affects pulmonary arterial pressure in heart failure with preserved ejection fraction and pulmonary hypertension.
    ESC Heart Fail. 2022 May 19. doi: 10.1002/ehf2.13952.
    PubMed    
    Abstract available

  137. RUIGROK D, Handoko ML, Meijboom LJ, Nossent EJ, et al
    Noninvasive follow-up strategy after pulmonary endarterectomy for chronic thromboembolic pulmonary hypertension.
    ERJ Open Res. 2022;8.
    PubMed    
    Abstract available

  138. ALKHANFAR D, Shahin Y, Alandejani F, Dwivedi K, et al
    Severe pulmonary hypertension associated with lung disease is characterised by a loss of small pulmonary vessels on quantitative computed tomography.
    ERJ Open Res. 2022;8.
    PubMed    
    Abstract available

  139. BIER EA, Alenezi F, Lu J, Wang Z, et al
    Noninvasive diagnosis of pulmonary hypertension with hyperpolarised (129)Xe magnetic resonance imaging and spectroscopy.
    ERJ Open Res. 2022;8.
    PubMed    
    Abstract available

  140. WADA TT, Yokota K, Iida S, Kanno Y, et al
    Transition from epoprostenol to selexipag in a patient with systemic sclerosis and pulmonary hypertension during the postoperative period of colon cancer surgery: A case report.
    J Scleroderma Relat Disord. 2022;7:NP4-NP8.
    PubMed    
    Abstract available

  141. JOHNY D, Subramanyam K, Bhandary RM, Rao A, et al
    Non-surgical treatment of Lutembacher syndrome: combined percutaneous transcatheter therapy.
    BMJ Case Rep. 2022;15.
    PubMed    
    Abstract available

  142. RANGEL BSDS, Biselli B, Quintanilha NR, Avila MS, et al
    Early reduction of pulmonary arterial hypertension in patients using a long-term mechanical ventricular assistance device: a cross-sectional study.
    Sao Paulo Med J. 2022;140:505-508.
    PubMed    
    Abstract available

  143. SCOTT JV, Tembulkar TU, Lee ML, Faliks BT, et al
    Right ventricular myocardial energetic model for evaluating right heart function in pulmonary arterial hypertension.
    Physiol Rep. 2022;10:e15136.
    PubMed    
    Abstract available

  144. YU M, Wu X, Wang J, He M, et al
    Paeoniflorin attenuates monocrotaline-induced pulmonary arterial hypertension in rats by suppressing TAK1-MAPK/NF-kappaB pathways.
    Int J Med Sci. 2022;19:681-694.
    PubMed    
    Abstract available

  145. D'ADDARIO CA, Lanier GM, Jacob C, Bauer N, et al
    Differences in the expression of DNA methyltransferases and demethylases in leukocytes and the severity of pulmonary arterial hypertension between ethnic groups.
    Physiol Rep. 2022;10:e15282.
    PubMed    
    Abstract available

  146. LIM MX, Ismail AJ, Yeap TB
    Challenges in managing a critically ill patient with decompensated Eisenmenger syndrome.
    BMJ Case Rep. 2022;15.
    PubMed    
    Abstract available

  147. LV GJ, Li AL, Tao XC, Zhai YN, et al
    The accuracy and influencing factors of Doppler echocardiography in estimating pulmonary artery systolic pressure: comparison with right heart catheterization: a retrospective cross-sectional study.
    BMC Med Imaging. 2022;22:91.
    PubMed    
    Abstract available

  148. STEPNIEWSKI J, Magon W, Waligora M, Jonas K, et al
    Hemodynamic effects of balloon pulmonary angioplasty for the treatment of total and subtotal pulmonary artery occlusions in inoperable chronic thromboembolic pulmonary hypertension.
    Int J Cardiol. 2022 May 13. pii: S0167-5273(22)00738.
    PubMed    
    Abstract available

  149. CHAKRABORTY S, Das SK, Lorente-Ros M, Patel N, et al
    Impact of pulmonary hypertension in patients with hypertrophic cardiomyopathy presented with cardiogenic shock/acute decompensated heart failure.
    Curr Probl Cardiol. 2022 May 13:101251. doi: 10.1016/j.cpcardiol.2022.101251.
    PubMed    
    Abstract available

  150. SHANG ST, Chang YL, Ho WJ, Liu CY, et al
    Quality of Life in Patients With Pulmonary Hypertension.
    Clin Nurs Res. 2022 May 16:10547738221096558. doi: 10.1177/10547738221096558.
    PubMed    
    Abstract available

  151. BERTERO T, Lu Y, Annis S, Hale A, et al
    Systems-level regulation of microRNA networks by miR-130/301 promotes pulmonary hypertension.
    J Clin Invest. 2022;132.
    PubMed    


  152. UDOMKIATTIKUL J, Kirdratanasak N, Siritianwanitchakul P, Worapunyaanun W, et al
    Factors related to survival time in dogs with pulmonary hypertension secondary to degenerative mitral valve disease stage C.
    Int J Vet Sci Med. 2022;10:25-32.
    PubMed    
    Abstract available

  153. WU S, Peng G, Xu C, Li X, et al
    The outcome of lung transplantation for end-stage pulmonary diseases with pulmonary hypertension: a single-center experience.
    J Thorac Dis. 2022;14:1020-1030.
    PubMed    
    Abstract available

  154. VAN UDEN D, Koudstaal T, van Hulst JAC, van den Bosch TPP, et al
    Evidence for a Role of CCR6+ T Cells in Chronic Thromboembolic Pulmonary Hypertension.
    Front Immunol. 2022;13:861450.
    PubMed    
    Abstract available

  155. BENAVIDES-CORDOBA V, Spruit MA
    Muscle training in patients with pulmonary hypertension. a narrative review.
    Colomb Med (Cali). 2021;52:e2015163.
    PubMed    
    Abstract available

  156. RUBACKOVA POPELOVA J, Tomkova M, Tomek J, Zivna R, et al
    Long-Term Survival of Adult Patients With Atrial Septal Defect With Regards to Defect Closure and Pulmonary Hypertension.
    Front Cardiovasc Med. 2022;9:867012.
    PubMed    
    Abstract available

  157. SIMAKOVA MA, Zlobina IS, Berezina AV, Marukyan NV, et al
    Cardiopulmonary exercise testing for treatment effect assessment in chronic thromboembolic pulmonary hypertension patients.
    Kardiologiia. 2022;62:44-54.
    PubMed    
    Abstract available

  158. MULLER BA, Diab KA
    Pulmonary hypertension in pregnancy and its effects on the fetus.
    Semin Fetal Neonatal Med. 2022 Apr 22:101348. doi: 10.1016/j.siny.2022.101348.
    PubMed    
    Abstract available

  159. ZHOU Y, Panda A, Jokerst CE
    Editorial for "Evaluation of Pulmonary Hypertension Using 4D Flow MRI".
    J Magn Reson Imaging. 2022 May 14. doi: 10.1002/jmri.28235.
    PubMed    


  160. MADONNA R, Fabiani S, Morganti R, Forniti A, et al
    Exercise-Induced Pulmonary Hypertension Is Associated with High Cardiovascular Risk in Patients with HIV.
    J Clin Med. 2022;11.
    PubMed    
    Abstract available

  161. MAGON W, Stepniewski J, Waligora M, Jonas K, et al
    Changes in Inflammatory Markers in Patients with Chronic Thromboembolic Pulmonary Hypertension Treated with Balloon Pulmonary Angioplasty.
    Cells. 2022;11.
    PubMed    
    Abstract available

  162. GONZALES J, Holbert K, Czysz K, George J, et al
    Hemin-Induced Endothelial Dysfunction and Endothelial to Mesenchymal Transition in the Pathogenesis of Pulmonary Hypertension Due to Chronic Hemolysis.
    Int J Mol Sci. 2022;23.
    PubMed    
    Abstract available

  163. BARILLI M, Tavera MC, Valente S, Palazzuoli A, et al
    Structural and Hemodynamic Changes of the Right Ventricle in PH-HFpEF.
    Int J Mol Sci. 2022;23.
    PubMed    
    Abstract available

  164. WANG M, Li X, Chen L
    An enhance multimodal multiobjective optimization genetic algorithm with special crowding distance for pulmonary hypertension feature selection.
    Comput Biol Med. 2022;146:105536.
    PubMed    
    Abstract available

  165. LIN S, Hua X, Li J, Li Y, et al
    Novel Compound Heterozygous PKLR Mutation Induced Pyruvate Kinase Deficiency With Persistent Pulmonary Hypertension in a Neonate: A Case Report.
    Front Cardiovasc Med. 2022;9:872172.
    PubMed    
    Abstract available

  166. TAS S, Antal A, Durusoy AF, Yanartas M, et al
    Pulmonary Endarterectomy in Patients with Antiphospholipid Syndrome-Associated Chronic Thromboembolic Pulmonary Hypertension.
    Anatol J Cardiol. 2022;26:394-400.
    PubMed    
    Abstract available

  167. AKGUN AE, Yaylali YT, Secme M, Dodurga Y, et al
    Kynurenine-PARP-1 Link Mediated by MicroRNA 210 May Be Dysregulated in Pulmonary Hypertension.
    Anatol J Cardiol. 2022;26:388-393.
    PubMed    
    Abstract available

  168. EROL C
    Focus on Micro RNAs and Pulmonary Hypertension.
    Anatol J Cardiol. 2022;26:345.
    PubMed    


  169. JOSHI SR, Liu J, Bloom T, Karaca Atabay E, et al
    Sotatercept analog suppresses inflammation to reverse experimental pulmonary arterial hypertension.
    Sci Rep. 2022;12:7803.
    PubMed    
    Abstract available

  170. BAPTISTA DE BARROS RIBEIRO DOU, Santos M, Moreira-Goncalves D
    Nets, pulmonary arterial hypertension, and thrombo-inflammation.
    J Mol Med (Berl). 2022;100:713-722.
    PubMed    
    Abstract available

  171. FUKUMITSU M, Groeneveldt JA, Braams NJ, Bayoumy AA, et al
    When right ventricular pressure meets volume: The impact of arrival time of reflected waves on right ventricle load in pulmonary arterial hypertension.
    J Physiol. 2022;600:2327-2344.
    PubMed    
    Abstract available

  172. DING J, Chu C, Mao Z, Yang J, et al
    Metabolomics-based mechanism exploration of pulmonary arterial hypertension pathogenesis: novel lessons from explanted human lungs.
    Hypertens Res. 2022;45:990-1000.
    PubMed    
    Abstract available

  173. YANG C, Rong R, Li Y, Cheng M, et al
    Decrease in LINC00963 attenuates the progression of pulmonary arterial hypertension via microRNA-328-3p/profilin 1 axis.
    J Clin Lab Anal. 2022;36:e24383.
    PubMed    
    Abstract available

  174. THOMAS S, Manivannan S, Garg V, Lilly B, et al
    Single-Cell RNA Sequencing Reveals Novel Genes Regulated by Hypoxia in the Lung Vasculature.
    J Vasc Res. 2022;59:163-175.
    PubMed    
    Abstract available

  175. KHALILIAN MR, Ziaratban M, Alizadeh P, Norouzi AR, et al
    Comparison of QT dispersion before and after PDA device closure in pediatrics.
    Ann Noninvasive Electrocardiol. 2022;27:e12945.
    PubMed    
    Abstract available

  176. SOMEYA Y, Koyasu S, Ohnishi Y, Ohno T, et al
    Pancreatic enlargement in a patient receiving therapy with vasodilators for pulmonary arterial hypertension: a case report.
    Abdom Radiol (NY). 2022;47:1948-1953.
    PubMed    
    Abstract available

  177. WANG J, Jiang R, Tan Y, Cheng K, et al
    Human pulmonary artery smooth muscle cell dysfunction is regulated by miR-509-5p in hypoxic environment.
    Cell Cycle. 2022;21:1212-1221.
    PubMed    
    Abstract available

  178. ZHANG G, Kang Y, Cathey D, LeBlanc AJ, et al
    Sulforaphane Does Not Protect Right Ventricular Systolic and Diastolic Functions in Nrf2 Knockout Pulmonary Artery Hypertension Mice.
    Cardiovasc Drugs Ther. 2022;36:425-436.
    PubMed    
    Abstract available

  179. ZHANG Y, Qin D, Qin L, Yang X, et al
    Answer to Simopoulou et al. "On the diagnostic test accuracy of N-terminal pro-brain natriuretic peptide (NT-proBNP) for pulmonary arterial hypertension in patients with systemic sclerosis". Joint Bone Spine 2021;89:105317.
    Joint Bone Spine. 2022;89:105323.
    PubMed    


  180. SAGONAS I, Daoussis D
    Serotonin and systemic sclerosis. An emerging player in pathogenesis.
    Joint Bone Spine. 2022;89:105309.
    PubMed    
    Abstract available

  181. PALASSIN P, Maria ATJ, Ladhari C, Quantin X, et al
    Pulmonary hypertension reported with immune checkpoint inhibitors: a pharmacovigilance study.
    Cancer Immunol Immunother. 2022 May 26. pii: 10.1007/s00262-022-03208.
    PubMed    
    Abstract available

  182. GELPI RJ
    A New Therapeutic Alternative for the Treatment of Pulmonary Hypertension?
    Arq Bras Cardiol. 2021;117:1113-1114.
    PubMed    


  183. WANG G, Tao X, Peng L
    miR-155-5p regulates hypoxia-induced pulmonary artery smooth muscle cell function by targeting PYGL.
    Bioengineered. 2022;13:12985-12997.
    PubMed    
    Abstract available

  184. ASSERI AA, Asiri IA, Alwabel HH, Asiri AM, et al
    Severe acute reentry high altitude pulmonary edema in pediatric patients: report of three cases and literature review.
    Turk J Pediatr. 2022;64:400-407.
    PubMed    
    Abstract available

  185. PARK MH, Lee MJ, Kim JS, Park SH, et al
    Veno-venous extracorporeal membrane oxygenation rescue for pulmonary hypertension and hypoxemic respiratory failure to obesity hypoventilation syndrome: a case report.
    Ann Palliat Med. 2022 May 12. pii: apm-22-178. doi: 10.21037.
    PubMed    
    Abstract available

  186. ZHOU F, Zheng Z, Pan Y
    Pulmonary artery dissection secondary to pulmonary hypertension due to patent ductus arteriosus: echocardiography and computed tomography findings.
    Acta Cardiol. 2022 May 24:1-2. doi: 10.1080/00015385.2022.2054496.
    PubMed    


  187. BURKI T
    Pulmonary hypertension in Europe: a call to action.
    Lancet Respir Med. 2022 May 20. pii: S2213-2600(22)00190.
    PubMed    


  188. BROOKS BA, Krishnan A, d'Udekem Y, Yurasek GK, et al
    Transposition With Hypertrophic Cardiomyopathy and Persistent Pulmonary Hypertension of the Newborn.
    World J Pediatr Congenit Heart Surg. 2022 May 23:21501351221098135.
    PubMed    
    Abstract available

  189. CROQUETTE M, Puyade M, Montani D, Jutant EM, et al
    Diagnostic Performance of Pulsed Doppler Ultrasound of the Common Femoral Vein to Detect Elevated Right Atrial Pressure in Pulmonary Hypertension.
    J Cardiovasc Transl Res. 2022 May 23. pii: 10.1007/s12265-022-10276.
    PubMed    
    Abstract available

  190. GONZALEZ-GARCIA M, Aguirre-Franco CE, Vargas-Ramirez L, Barrero M, et al
    Effect of pulmonary hypertension on exercise capacity and gas exchange in patients with chronic obstructive pulmonary disease living at high altitude.
    Chron Respir Dis. 2022;19:14799731221104095.
    PubMed    
    Abstract available

  191. MA X, Wang XE, Xie LX, Lu S, et al
    The Levels of TNF-alpha, Tissue Factor, and Coagulation Function in Rats with Pulmonary Hypertension and the Intervention Effect of Sildenafil Encapsulated by Targeted Nanocarriers.
    Comput Math Methods Med. 2022;2022:8619092.
    PubMed    
    Abstract available

  192. WU P, Zhu T, Tan Z, Chen S, et al
    Role of Gut Microbiota in Pulmonary Arterial Hypertension.
    Front Cell Infect Microbiol. 2022;12:812303.
    PubMed    
    Abstract available

  193. BOLT MA, MaWhinney S, Pattee JW, Erlandson KM, et al
    Inference following multiple imputation for generalized additive models: an investigation of the median p-value rule with applications to the Pulmonary Hypertension Association Registry and Colorado COVID-19 hospitalization data.
    BMC Med Res Methodol. 2022;22:148.
    PubMed    
    Abstract available

  194. PANAKALA S, Anumolu AR, Khatri M
    Prevalence of sexual dysfunction in women with pulmonary hypertension and associated variables.
    Heart Lung. 2022;55:146-147.
    PubMed    


  195. COOPER TJ, Cleland JG, Guazzi M, Pellicori P, et al
    Effects of sildenafil on symptoms and exercise capacity for heart failure with reduced ejection fraction and pulmonary hypertension (The SilHF study): A randomised placebo-controlled multicentre trial.
    Eur J Heart Fail. 2022 May 21. doi: 10.1002/ejhf.2527.
    PubMed    
    Abstract available

  196. AZZO L, Ali YS, Vaqar S, Yildiz Bolukbasi E, et al
    Do paternal deletions involving the FOXF1 locus on chromosome 16q24.1 manifest with more severe non-lung anomalies?
    Eur J Med Genet. 2022;65:104519.
    PubMed    
    Abstract available

  197. YE B, Peng X, Su D, Liu D, et al
    Effects of YM155 on the proliferation and apoptosis of pulmonary artery smooth muscle cells in a rat model of high pulmonary blood flow-induced pulmonary arterial hypertension.
    Clin Exp Hypertens. 2022 May 4:1-10. doi: 10.1080/10641963.2022.2071919.
    PubMed    
    Abstract available

  198. TANI C, Elefante E, Arnaud L, Barreira SC, et al
    Rare clinical manifestations in systemic lupus erythematosus: a review on frequency and clinical presentation.
    Clin Exp Rheumatol. 2022;40 Suppl 134:93-102.
    PubMed    
    Abstract available

  199. KYNTA RL, Rawat S, Mandal M, Saikia MK, et al
    Pulmonary Thromboendarterectomy Without Circulatory Arrest.
    Braz J Cardiovasc Surg. 2022;37:394-400.
    PubMed    
    Abstract available

  200. GUREL DURMUS Z, Bulbul Y, Tekinbas C, Seyis KN, et al
    Frequency and Predictors of Pulmonary Arterial Stump Thrombosis following Pneumonectomy or Lobectomy.
    Med Princ Pract. 2022;31:174-179.
    PubMed    
    Abstract available

  201. AL-YAARUBI S, Al-Abri AS, Al-Kindi H, Al-Abri M, et al
    Sanjad Sakati syndrome and sleep-disordered breathing: an undisclosed association.
    Sleep Breath. 2022;26:815-821.
    PubMed    
    Abstract available

  202. ERTAN O, Aslan GK, Akinci B, Bilge AK, et al
    Effect of Ground-Based Walk Training in Pulmonary Hypertension.
    Am J Cardiol. 2022 Apr 23. pii: S0002-9149(22)00344.
    PubMed    
    Abstract available

  203. CHEN J, Rodriguez M, Miao J, Liao J, et al
    Mechanosensitive channel Piezo1 is required for pulmonary artery smooth muscle cell proliferation.
    Am J Physiol Lung Cell Mol Physiol. 2022;322:L737-L760.
    PubMed    
    Abstract available

  204. LU M, Chen LY, Gairhe S, Mazer AJ, et al
    Mineralocorticoid receptor antagonist treatment of established pulmonary arterial hypertension improves interventricular dependence in the SU5416-hypoxia rat model.
    Am J Physiol Lung Cell Mol Physiol. 2022;322:L315-L332.
    PubMed    
    Abstract available

  205. CUNNINGHAM CM, Li M, Ruffenach G, Doshi M, et al
    Y-Chromosome Gene, Uty, Protects Against Pulmonary Hypertension by Reducing Proinflammatory Chemokines.
    Am J Respir Crit Care Med. 2022 May 3. doi: 10.1164/rccm.202110-2309.
    PubMed    
    Abstract available

  206. SINGH N, Ventetuolo CE
    Prime Time for Proteomics in Pulmonary Arterial Hypertension Risk Assessment?
    Am J Respir Crit Care Med. 2022;205:988-990.
    PubMed    


  207. RHODES CJ, Wharton J, Swietlik EM, Harbaum L, et al
    Using the Plasma Proteome for Risk Stratifying Patients with Pulmonary Arterial Hypertension.
    Am J Respir Crit Care Med. 2022;205:1102-1111.
    PubMed    
    Abstract available

  208. ALBA GA
    Double Jeopardy: Precapillary Pulmonary Hypertension Increases the Risk of Hospitalization and Death from COVID-19.
    Am J Respir Crit Care Med. 2022 May 18. doi: 10.1164/rccm.202205-0884.
    PubMed    


  209. CONSTANTINE A, Dimopoulos K, Haworth SG, Muthurangu V, et al
    Twenty-year experience and outcomes in a National Pediatric Pulmonary Hypertension Service.
    Am J Respir Crit Care Med. 2022 May 17. doi: 10.1164/rccm.202110-2428.
    PubMed    
    Abstract available

  210. MONTANI D, Certain MC, Weatherald J, Jais X, et al
    COVID-19 in Patients with Pulmonary Hypertension: A National Prospective Cohort Study.
    Am J Respir Crit Care Med. 2022 May 12. doi: 10.1164/rccm.202112-2761.
    PubMed    
    Abstract available

  211. RAO R, Chan SY
    A dUTY to Protect: Addressing "Y" We See Sex Differences in Pulmonary Hypertension.
    Am J Respir Crit Care Med. 2022 May 12. doi: 10.1164/rccm.202204-0653.
    PubMed    


  212. JIN Q, Guan L, Pan W, Zhang X, et al
    Inhaled Treprostinil after Initial Clinical Worsening: To Continue or Not to Continue, That's the Question.
    Am J Respir Crit Care Med. 2022;205:1250-1251.
    PubMed    


  213. LAPATRA T, Baird GL, Goodman R, Pinder D, et al
    Reply to: Remote 6-minute Walk Testing in Patients with Pulmonary Hypertension: Further Validation Needed?
    Am J Respir Crit Care Med. 2022 May 24. doi: 10.1164/rccm.202205-0867.
    PubMed    


  214. HELGESON SA, Burger CD, Moss JE, Zeiger TK, et al
    Remote 6-minute Walk Testing in Patients with Pulmonary Hypertension: Further Validation Needed?
    Am J Respir Crit Care Med. 2022 May 24. doi: 10.1164/rccm.202204-0762.
    PubMed    


  215. AL-KHALDI A, Momenah T, Alsahari A, Alotay A, et al
    Late Outcomes After Pulmonary Arterial Reconstruction in Patients With Arterial Tortuosity Syndrome.
    Ann Thorac Surg. 2022;113:1569-1574.
    PubMed    
    Abstract available

  216. HADDAD F, Contrepois K, Amsallem M, Denault AY, et al
    The Right Heart Network and Risk Stratification in Pulmonary Arterial Hypertension.
    Chest. 2022;161:1347-1359.
    PubMed    
    Abstract available

  217. HUSTON JH, Shah SJ
    Understanding the Pathobiology of Pulmonary Hypertension Due to Left Heart Disease.
    Circ Res. 2022;130:1382-1403.
    PubMed    
    Abstract available

  218. RHODES CJ, Sweatt AJ, Maron BA
    Harnessing Big Data to Advance Treatment and Understanding of Pulmonary Hypertension.
    Circ Res. 2022;130:1423-1444.
    PubMed    
    Abstract available

  219. SINGH N, Dorfmuller P, Shlobin OA, Ventetuolo CE, et al
    Group 3 Pulmonary Hypertension: From Bench to Bedside.
    Circ Res. 2022;130:1404-1422.
    PubMed    
    Abstract available

  220. BOUCHERAT O, Agrawal V, Lawrie A, Bonnet S, et al
    The Latest in Animal Models of Pulmonary Hypertension and Right Ventricular Failure.
    Circ Res. 2022;130:1466-1486.
    PubMed    
    Abstract available

  221. ALDRED MA, Morrell NW, Guignabert C
    New Mutations and Pathogenesis of Pulmonary Hypertension: Progress and Puzzles in Disease Pathogenesis.
    Circ Res. 2022;130:1365-1381.
    PubMed    
    Abstract available

  222. KUDRYASHOVA TV, Dabral S, Nayakanti S, Ray A, et al
    Noncanonical HIPPO/MST Signaling via BUB3 and FOXO Drives Pulmonary Vascular Cell Growth and Survival.
    Circ Res. 2022;130:760-778.
    PubMed    
    Abstract available

  223. ALENEZI F, Covington TA, Mukherjee M, Mathai SC, et al
    Novel Approaches to Imaging the Pulmonary Vasculature and Right Heart.
    Circ Res. 2022;130:1445-1465.
    PubMed    
    Abstract available

  224. AZZO L, Ali YS, Vaqar S, Dauriat G, et al
    Severe pulmonary hypertension associated with chronic obstructive pulmonary disease Long-term results of a prospective French multicenter cohort.
    Eur Respir J. 2022 May 20. pii: 13993003.02897-2021.
    PubMed    
    Abstract available

  225. NEDER JA, Phillips DB, O'Donnell DE, Dempsey JA, et al
    Excess ventilation and exertional dyspnoea in heart failure and pulmonary hypertension.
    Eur Respir J. 2022 May 26. pii: 13993003.00144-2022.
    PubMed    
    Abstract available

  226. TAKAYA Y, Akagi T, Sakamoto I, Kanazawa H, et al
    Efficacy of treat-and-repair strategy for atrial septal defect with pulmonary arterial hypertension.
    Heart. 2022;108:382-387.
    PubMed    
    Abstract available

  227. CAI H, Fan S, Cai L, Zhu L, et al
    Dihydroartemisinin attenuates hypoxia-induced pulmonary hypertension through the ELAVL2/miR-503/PI3K/AKT axis.
    J Cardiovasc Pharmacol. 2022 May 5. pii: 00005344-990000000-00028.
    PubMed    
    Abstract available


  228. ZIP12 Contributes to Hypoxic Pulmonary Hypertension by Driving Phenotypic Switching of Pulmonary Artery Smooth Muscle Cells: Erratum.
    J Cardiovasc Pharmacol. 2022;79:758.
    PubMed    


  229. WEATHERALD J, Thakrar MV, Varughese RA, Kularatne M, et al
    Upfront riociguat and ambrisentan combination therapy for newly diagnosed pulmonary arterial hypertension: A prospective open-label trial.
    J Heart Lung Transplant. 2022;41:563-567.
    PubMed    
    Abstract available

  230. BADAGLIACCA R, Rischard F, Giudice FL, Howard L, et al
    Incremental value of cardiopulmonary exercise testing in intermediate-risk pulmonary arterial hypertension.
    J Heart Lung Transplant. 2022;41:780-790.
    PubMed    
    Abstract available

  231. ABDELNOUR-BERCHTOLD E, Donahoe L, McRae K, Asghar U, et al
    Central venoarterial extracorporeal membrane oxygenation as a bridge to recovery after pulmonary endarterectomy in patients with decompensated right heart failure.
    J Heart Lung Transplant. 2022;41:773-779.
    PubMed    
    Abstract available

  232. SUN QW, Sun Z
    Stem cell therapy for pulmonary arterial hypertension: An update.
    J Heart Lung Transplant. 2022;41:692-703.
    PubMed    
    Abstract available

  233. MEMON N, Griffin I
    Correspondence: "Patent ductus arteriosus shunt elimination results in a reduction in adverse outcomes: a post hoc analysis of the PDA RCT cohort".
    J Perinatol. 2022;42:692.
    PubMed    


  234. GIULINI L, Mittal SK, Masuda T, Razia D, et al
    Factors associated with esophageal motility improvement after bilateral lung transplant in patients with an aperistaltic esophagus.
    J Thorac Cardiovasc Surg. 2022;163:1979-1986.
    PubMed    
    Abstract available

  235. VICENZI M, Caravita S, Rota I, Casella R, et al
    The added value of right ventricular function normalized for afterload to improve risk stratification of patients with pulmonary arterial hypertension.
    PLoS One. 2022;17:e0265059.
    PubMed    
    Abstract available


Thank you for your interest in scientific medicine.


AMEDEO Pulmonary Hypertension is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.

Design:


;